Cim Investment Management Inc Biogen Inc. Transaction History

Cim Investment Management Inc

$321 Million
Q2 2024

A detailed history of Cim Investment Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Cim Investment Management Inc holds 2,929 shares of BIIB stock, worth $509,030. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,929

Previous 2,946 0.58%

Holding current value

$509,030

Previous $635,000 6.93%

% of portfolio

0.21%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$190.52 - $236.72 $3,238 - $4,024	-17 Reduced 0.58%	2,929 $679,000
Q4 2023 Feb 15, 2024	SELL	$222.59 - $267.94 $28,936 - $34,832	-130 Reduced 4.23%	2,946 $762,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $18,237 - $20,584	-72 Reduced 2.29%	3,076 $790,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $6,055 - $6,997	22 Added 0.7%	3,148 $896,000
Q1 2023 May 16, 2023	BUY	$256.56 - $292.34 $37,714 - $42,973	147 Added 4.93%	3,126 $869,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $406,933 - $494,432	-1,612 Reduced 35.11%	2,979 $824,000
Q2 2022 Sep 02, 2022	SELL	$187.54 - $223.02 $4,500 - $5,352	-24 Reduced 0.52%	4,591 $936,000
Q1 2022 May 17, 2022	SELL	$193.77 - $244.14 $968 - $1,220	-5 Reduced 0.11%	4,615 $972,000
Q4 2021 May 19, 2022	SELL	$223.92 - $287.77 $897,695 - $1.15 Million	-4,009 Reduced 46.46%	4,620 $1.11 Million
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $1.03 Million - $1.33 Million	4,620 Added 115.24%	8,629 $2.24 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $363,925 - $474,598	1,286 Added 47.23%	4,009 $1.14 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $16,058 - $25,712	-62 Reduced 2.23%	2,723 $943,000
Q1 2021 May 20, 2021	SELL	$242.95 - $284.63 $727,149 - $851,897	-2,993 Reduced 51.8%	2,785 $779,000
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $1.03 Million - $1.55 Million	4,372 Added 310.95%	5,778 $1.42 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $3,442 - $3,974	-13 Reduced 0.92%	1,406 $399,000
Q1 2020 May 22, 2020	BUY	$268.85 - $341.04 $11,560 - $14,664	43 Added 3.13%	1,419 $449,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $30,441 - $34,143	-140 Reduced 9.23%	1,376 $320,000
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $14,253 - $15,711	65 Added 4.48%	1,516 $355,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $316,613 - $495,220	-1,461 Reduced 50.17%	1,451 $343,000
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $406,888 - $515,367	1,461 Added 100.69%	2,912 $876,000
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $9,528 - $11,355	-37 Reduced 2.49%	1,451 $421,000
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $8,844 - $12,508	-34 Reduced 2.23%	1,488 $407,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $468,228 - $524,450	1,522	1,522 $485,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Biogen Inc. Transaction History